Measurement of pulmonary flow reserve and pulmonary index of microcirculatory resistance for detection of pulmonary microvascular obstruction

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Ilsar, Rahn ^a,b   Chawantanpipat, Chirapan ^a   Chan, Kim H ^a   Dobbins, Timothy A ^c   Waugh, Richard ^a   Hennessy, Annemarie ^d   Celermajer, David S ^a,b   Ng, Martin K C ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; MICROSPHERE; PAPAVERINE; VASODILATOR AGENT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BABOON; CERAMICS; CONTROLLED STUDY; GUIDE WIRE; HEMODYNAMICS; HYPEREMIA; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG FUNCTION; LUNG VASCULAR RESISTANCE; NONHUMAN; PEAK EXPIRATORY FLOW; PULMONARY VASCULAR OBSTRUCTIVE DISEASE; REPRODUCIBILITY; SENSOR; TEMPERATURE; THERMODILUTION; ANIMAL; BLOOD FLOW VELOCITY; CARDIOLOGY; DRUG EFFECT; LUNG; METHODOLOGY; MICROCIRCULATION; PATHOLOGY; PRESSURE; PULMONARY ARTERY; VASCULARIZATION;

PAPIO; PRIMATES;

ADENOSINE; ANIMALS; BLOOD FLOW VELOCITY; CARDIOLOGY; HEMODYNAMICS; LUNG; MICROCIRCULATION; MICROSPHERES; PAPAVERINE; PAPIO; PRESSURE; PULMONARY ARTERY; PULMONARY CIRCULATION; TEMPERATURE; VASODILATOR AGENTS;

EID: 77949765685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009601     Document Type: Article

References (35)

1. Bhattacharya J, Staub NC (1980) Direct measurement of microvascular pressures in the isolated perfused dog lung. Science 210: 327-328.
2. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, et al. (2004) Pathologic assessment of vasculopathies in pulmonary hypertension. Journal of the American College of Cardiology 43: 25S-32S.
3. Galie N, Kim NHS (2006) Pulmonary Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension. Proceedings of the American Thoracic Society 3: 571-576.
4. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M (2007) A USA-based registry for pulmonary arterial hypertension: 1982-2006. European Respiratory Journal 30: 1103-1110.
5. Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF (2007) Chronic thromboembolic pulmonary hypertension. Clinics in Chest Medicine 28: 255-269.
6. McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, et al. (2004) Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126: 78S-92S.
7. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, et al. (2006) Pulmonary arterial hypertension in France: results from a national registry. American Journal of Respiratory and Critical Care Medicine 173: 1023-1030.
8. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, et al. (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. Journal of the American College of Cardiology 43: S40-S47.
9. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, et al. (1992) Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 85: 1899-1911.
10. De Bruyne B, Pijls NH, Smith L, Wievegg M, Heyndrickx GR (2001) Coronary thermodilution to assess flow reserve: experimental validation. Circulation 104: 2003-2006.
11. Fearon WF, Farouque HMO, Balsam LB, Caffarelli AD, Cooke DT, et al. (2003) Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve. Circulation 108: 2198-2200.
12. Kern MJ (2000) Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation 101: 1344-1351.
13. Fearon WF, Balsam LB, Farouque HMO, Caffarelli AD, Robbins RC, et al. (2003) Novel Index for Invasively Assessing the Coronary Microcirculation. Circulation 107: 3129-3132.
14. Fearon WF, Aarnoudse W, Pijls NHJ, De Bruyne B, Balsam LB, et al. (2004) Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation 109: 2269-2272.
15. Ng MK, Yeung AC, Fearon WF (2006) Invasive Assessment of the Coronary Microcirculation. Superior Reproducibility and Less Hemodynamic Dependence of Index of Microcirculatory Resistance Compared With Coronary Flow Reserve. Circulation 113: 2054-2061.
16. Celermajer DS, Cullen S, Deanfield JE (1993) Impairment of endotheliumdependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87: 440-446.
17. Ilsar R, Chawantanpipat C, Chan KH, Waugh R, Hennessy A, et al. (2009) Measurement of pulmonary flow reserve in higher primates. Clinical and Experimental Pharmacology and Physiology 36: 797-802.
18. Pijls NH, De Bruyne B, Smith L, Aarnoudse W, Barbato E, et al. (2002) Coronary thermodilution to assess flow reserve: validation in humans. Circulation 105: 2482-2486.
19. Barbato E, Aarnoudse W, Aengevaeren WR, Werner G, Klauss V, et al. (2004) Validation of coronary flow reserve measurements by thermodilution in clinical practice. European Heart Journal 25: 219-223.
20. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82: 1595-1606.
21. Wilson RF, White CW (1986) Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 73: 444-451.
22. Lumb A (2000) Applied Respiratory Physiology: Reed Educational and Professional Publishing.
23. Lovering AT, Stickland MK, Kelso AJ, Eldridge MW (2007) Direct demonstration of 25- and 50-microm arteriovenous pathways in healthy human and baboon lungs. American Journal of Physiology - Heart & Circulatory Physiology 292: H1777-1781.
24. Zijlstra F, Serruys PW, Hugenholtz PG (1986) Papaverine: the ideal coronary vasodilator for investigating coronary flow reserve? A study of timing, magnitude, reproducibility, and safety of the coronary hyperemic response after intracoronary papaverine. Catheterization & Cardiovascular Diagnosis 12: 298-303.
25. Galie N, Rubin LJ, Hoeper MM, Jansa P, Al-Hiti H, et al. (2008) Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 371: 2093-2100.
26. Bush A, Busst CM, Clarke B, Barnes PJ (1989) Effect of infused adenosine on cardiac output and systemic resistance in normal subjects. British Journal of Clinical Pharmacology 27: 165-171.
27. Radegran G, Calbet JA (2001) Role of adenosine in exercise-induced human skeletal muscle vasodilatation. Acta Physiologica Scandinavica 171: 177-185.
28. Fearon WF, Shah M, Ng M, Brinton T, Wilson A, et al. (2008) Predictive Value of the Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology 51: 560-565.
29. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, et al. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. Journal of the American College of Cardiology 43: S13-S24.
30. Johnson BD, Beck KC, Proctor DN, Miller J, Dietz NM, et al. (2000) Cardiac output during exercise by the open circuit acetylene washin method: comparison with direct Fick. Journal of Applied Physiology 88: 1650-1658.
31. White PF, Way WL, Trevor AJ (1982) Ketamine-Its Pharmacology and Therapeutic Uses. Anesthesiology 56: 119-136.
32. Ogawa K (2001) Inhibitory Effects of Etomidate and Ketamine on Endothelium-dependent Relaxation in Canine Pulmonary Artery. Anesthesiology 94: 668-677.
33. West JB, Dollery CT, Naimark A (1964) Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures. Journal of Applied Physiology 19: 713-724.
34. Glenny RW, Bernard S, Robertson HT, Hlastala MP (1999) Gravity is an important but secondary determinant of regional pulmonary blood flow in upright primates. Journal of Applied Physiology 86: 623-632.
35. Bressolette E, Dupuis J, Boman R, Doucet S, Cernacek P, et al. (2001) Intravascular ultrasound assessment of pulmonary vascular disease in patients with pulmonary hypertension. Chest 120: 809-815.